SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Somatogen (SMTG) -- Ignore unavailable to you. Want to Upgrade?


To: aknahow who wrote (417)2/26/1998 1:42:00 AM
From: Vector1  Read Replies (2) | Respond to of 442
 
George,
The $9 per share is in Baxter stock. The following is from the press release
<<Shareholders of Somatogen will get $9 worth of Baxter stock for each of their Somatogen shares.>>

The release is less clear about the contingent $2 which if it is ever paid will be a long time in coming.
V1